-+ 0.00%
-+ 0.00%
-+ 0.00%

Pasithea Therapeutics Q2 EPS $(0.66) Up From $(3.71) YoY

Benzinga·08/14/2025 21:55:40
Listen to the news
Pasithea Therapeutics (NASDAQ:KTTA) reported quarterly losses of $(0.66) per share. This is a 82.21 percent increase over losses of $(3.71) per share from the same period last year.